Abstract
Patients with metastatic colorectal cancer (mCRC) involving the liver present several therapeutic challenges for the oncology team. The majority of patients will not be candidates for potentially curative surgical resection and therefore must rely on other local therapies to augment systemic cheotherapy. Unlike some other solid tumors with liver métastases, mCRC patients now have access to a plethora of new biologic agents and cytotoxic drugs that did not exist a decade ago. Changes in liver arterial caliber and tolerance of liver lobules to radiation are both negatively effected by these new systemic therapies and have had an impact on aspects of microsphere therapy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Muller JH, Rossier PH (1951) A new method for the treatment of cancer of the lungs by means of artificial radioactivity (Zn63 and Aul98). Acta Radiol 35:449–468
Ya PM, Guzman T, Loken MK et al (1961) Isotope localization with tagged microspheres. Surgery 49:644–650
Di Matteo G, Gennarelli L, Lenti R (1962) Una nuova metodica per la fissazione elettiva delP Aul98 adsorbio su carbonio in terriori lobari e sublobari. Gazz Intern Med Chir 67:1875
Kim YS, LaFave JW, MacLean LD (1962) The Use of Radiating Microspheres in the Treatment of Experimental and Human Malignancy. Surgery 52:220
Grady ED, Sale WT, Rollins LC (1963) Localization of radioactivity by intravascular injection of large radioactive particles. Ann Surg 157:97–114
Ariel IM (1964) Radioactive isotopes for adjuvant cancer therapy. Arch Surg 89:244–249
Blanchard RJ, Grotenhuis I, LaFave JW (1964) Treatment of experimental tumors: utilization of radioactive micro-spheres. Arch Surg 89:406
Ariel IM (1965) Treatment of inoperable primary pancreatic and liver cancer by the intra-arterial administration of radioactive isotopes (Y90 radiating microspheres). Ann Surg 162:267–278
Blanchard RJ, LaFave JW, Kim YS (1965) Treatment of patients with advanced cancer using Y-90 microspheres. Cancer18:375
Caldarola L, Rosa U, Badellino F (1965) Preparation of 32P labelled resin microspheres for radiation treatment of tumors by intraarterial injection. Panminerva Med 7:102
Caldarola L, Badellino F, Del Fante FM (1966) L’impiego del P32 nel trattamento chirurgico dei tumori maligni oro-maxillo-faciali. Minerva Stomatol 15:471
Ariel IM, Pack GT (1967) Treatment of inoperable cancer of the liver by intra-arterial radioactive isotopes and chemotherapy. Cancer 20:793–804
Simon N, Warner RRP, Baron MG et al (1968) Intra-arterial irradiation of carcinoid tumors of the liver. Am J Roentgenol Radium Ther Nucl Med 102:552–561
Simon N, Silverstone SM, Roach LC et al (1971) Intra-arterial irradiation of tumors, a safe procedure. Am J Roent-genol Radium Ther Nucl Med 112:732–739
Lawrence TS, Robertson JM, Anscher MS et al (1995) Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys 31:1237–1248
Lax I, Blomgren H, Naslund I et al (1994) Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects. Acta Oncol 33:677–683
Sailer SL (2000) Three dimensional conformai radiotherapy. In: Gunderson L, Tepper J (eds) Clinical radiation oncology. Churchhill Livingstone, Philadelphia, pp 236–255
Dawson LA, Lawrence TS (2004) The role of radiotherapy in the treatment of liver métastases. Cancer J 10:139–144
Dawson LA, Ten Haken RK (2005) Partial volume tolerance of the liver to radiation. Semin Radiat Oncol 15:279–283
Lawrence TS, Ten Haken RK, Kessler ML et al (1992) The use of 3-D dose volume analysis to predict radiation hepatitis. Int J Radiat Oncol Biol Phys 23:781–788
Ricke J, Seidensticker M, Ludemann L et al (2005) In vivo assessment of the tolerance dose of small liver volumes after single-fraction HDR irradiation. Int J Radiat Oncol Biol Phys 62:776–784
Ricke J, Wust P, Stohlmann A et al (2004) CT-guided interstitial brachytherapy of liver malignancies alone or in combination with thermal ablation: phase I-II results of a novel technique. Int J Radiat Oncol Biol Phys 58:1496–1505
Nag S, DeHaan M, Scruggs G et al (2006) Long-term follow-up of patients of intrahepatic malignancies treated with iodine-125 brachytherapy. Int J Radiat Oncol Biol Phys 64:736–744
Müller JH, Rossier PH (1947) Treatment of cancer of the lungs by artificial radioactivity. Experientia 3:75
Grady ED, Sale WT, Rollins LC (1963) Localization of radioactivity by intravascular injection of large radioactive particles. Ann Surg 157:97–114
Nolan T, Grady ED, Crumbley AJ (1973) Regional internal radiation for hepatic cancer. Minerva Oncol 1:104–106
Nolan T, Grady ED, Crumbley AJ et al (1975) Internal hepatic radiotherapy: I. Organ distribution of colloidal Cr32 PO4 injected into a peripheral vein, the portal vein, or the arterial supply of the gastrointestinal tract in the rat. Am J Roentgenol Radium Ther Nucl Med 124:590–595
Grady ED, Nolan T, Larose JH et al (1975) Internal hepatic radiotherapy: II. Intra-arterial radiocolloid therapy for hepatic tumors. Am J Roentgenol Ther Nucl Med 124:596–599
Grady ED (1979) Internal radiation therapy of hepatic cancer. Dis Colon Rectum 22:371–375
Mantravadi RV, Spigos DG, Tan WS et al (1982) Intraarte-rial yttrium 90 in the treatment of hepatic malignancy. Radiology 142:783–786
Ariel IM, Padula G (1982) Treatment of asymptomatic metastatic cancer to the liver from primary colon and rectal cancer by the intraarterial administration of chemotherapy and radioactive isotopes. J Surg Oncol 20:151–156
Blanchard RJW (1983) Treatment of liver tumours with yttrium-90 microspheres. Can J Surg 26:442–443
Gyves JW, Ziessman HA, Ensminger WD et al (1984) Definition of hepatic tumor microcirculation by single photon emission computerized tomography (SPECT). J Nucl Med 25:972–977
Gray BN (1980) Colorectal cancer: the modern treatment of disseminated disease-a review. Aust N Z J Surg 50:647–658
Blanchard RJ, Morrow IM, Sutherland JB (1989) Treatment of liver tumors with yttrium-90 microspheres alone. Can Assoc Radiol J 40:206–210
Burton MA, Gray BN, Klemp PF et al (1989) Selective internal radiation therapy: distribution of radiation in the liver. Eur J Cancer Clin Oncol 25:1487–1491
Gray BN, Burton MA, Kelleher DK et al (1989) Selective internal radiation (SIR) therapy for treatment of liver métastases: measurement of response rate. J Surg Oncol 42:192–196.
Gray BN, Burton MA, Kelleher D et al (1990) Tolerance of the liver to the effects of Yttrium-90 radiation. Int J Radiat Oncol Biol Phys 18:619–623
Gray BN, Anderson JE, Burton MA et al (1992) Regression of liver métastases following treatment with yttrium-90 microspheres. Aust N Z J Surg 62:105–110
Anderson JH, Goldberg JA, Bessent RG et al (1992) Glass yttrium-90 microspheres for patients with colorectal liver métastases. Radiother Oncol 25:137–139
Gray BN (1980) Colorectal cancer: the natural history of disseminated disease-a review. Aust N Z J Surg 50:643–646
Marn CS, Andrews JC, Francis IR et al (1993) Hepatic parenchymal changes after intraarterial Y-90 therapy: CT findings. Radiology 187:125–128
Stribley KV, Gray BN, Chmiel RL et al (1983) Internal radiotherapy for hepatic métastases I: The homogeneity of hepatic arterial blood flow. J Surg Res 34:17–24
Stribley KV, Gray BN, Chmiel RL et al (1983) Internal radiotherapy for hepatic métastases II: The blood supply to hepatic métastases. J Surg Res 34:25–32
Burton MA, Gray BN, Jones C et al (1989) Intraoperative dosimetry of 90Y in liver tissue. Int J Rad Appl Instrum B 16:495–498
Fox RA, Klemp PF, Egan G et al (1991) Dose distribution following selective internal radiation therapy. Int J Radiat Oncol Biol Phys 21:463–467
Roberson PL, Ten Haken R, McShan DL et al (1992) Three-dimensional tumor dosimetry for hepatic Yttrium-90 microsphere therapy. J Nuclear Medicine 33:735–738
Burton MA, Gray BN, Coletti A (1988) Effect of angioten-sin II on blood flow in the transplanted sheep squamous cell carcinoma. Eur J Cancer Clin Oncol 24:1373–1376
Herba MJ, Illescas FF, Thirlwell MP et al (1988) Hepatic malignancies: improved treatment with intraarterial Y-90. Radiology 169:311–314
Ehrhardt G, Day DE (1987) Therapeutic use of 90Y micro-spheres. Int J Rad Appl Instrum B 14:233–242
Russell JJL, Carden JJL, Herron HL (1988) Dosimetry calculations for yttrium-90 used in the treatment of liver cancer. Endocurietherapy/Hyperthermia Oncology 4:171–186
Andrews JC, Walker SC, Ackermann RJ et al (1994) Hepatic radioembolization with yttrium-90 containing glass microspheres: preliminary results and clinical follow-up. J Nucl Med 35:1637–1644
Leung TW, Lau WY, Ho SK et al (1995) Radiation pneu-monitis after selective internal radiation treatment with intraarterial 90yttrium-microspheres for inoperable hepatic tumors. Int J Radiat Oncol Biol Phys 33:919–924
Harbert JC, Ziessman HA (1987) Therapy with intraarte-rial microspheres. Nuclear Medicine Annual 295–319
Ariel IM, Padula G (1978) Treatment of symptomatic met-astatic cancer to the liver from primary colon and rectal cancer by the intraarterial administration of chemotherapy and radioactive isotopes. J Surg Oncol 10:327–336
Herba M, Thirlwell MP (2002) Radioembolization for hepatic métastases. Semin Oncol 29:152–159
Kennedy AS, Coldwell D, Nutting C et al (2006) Resin 90Y-microsphere brachytherapy for unresectable colorectal liver métastases: modern USA experience. Int J Radiat Oncol Biol Phys 65:412–425
Stubbs RS, Cannan RJ, Mitchell AW (2001) Selective internal radiation therapy (SIRT) with 90Yttrium microspheres for extensive colorectal liver métastases. Hepatogastro-enterology 48:333–337
Stubbs RS, O’Brien I, Correia MM (2006) Selective internal radiation therapy with 90Y microspheres for colorec-tal liver métastases: single-centre experience with 100 patients. ANZ J Surg 76:696–703
Gray B, Van Hazel G, Hope M et al (2001) Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver métastases from pri-mary large bowel cancer. Ann Oncol 12:1711–1720
Lewandowski RJ, Thurston KG, Goin JE et al (2005) 90Y microsphere (TheraSphere) treatment for unresectable colorectal cancer métastases of the liver: response to treatment at targeted doses of 135-150 Gy as measured by [18F]fluorodeoxyglucose positron emission tomogra-phy and computed tomographic imaging. J Vasc Interv Radiol 16:1641–1651
Sharma RA, Van Hazel GA, Morgan B et al (2007) Radioembolization of liver métastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy. J Clin Oncol 25:1099–1106
Van Hazel G, Blackwell A, Anderson J, Price D, Moroz P, Bower G, Cardaci J, Gray B (2004) Randomised phase II trial of SIR-spheres plus flrorouracil/leucovrin chemotherapy versus fluororacil/leucovorin chemotherapy alone in advanced colorectal cancer. J Surg Oncol 88:78–85
Van Hazel G, Pavlakis N, Goldstein D et al (2005) Selective internal radiation therapy (SIRT) plus systemic chemotherapy with irinotecan. A phase I dose escalation study. Proceedings of the ASCO GI Cancers Symposium 223
Van Hazel G, Price D, Bower G et al (2005) Selective internal radiation therapy (SIRT) plus systemic chemotherapy with Oxaliplatin, 5-Fluorouracil and Leucovorin: A phase I dose escalation study. Proceedings of the ASCO GI Cancers Symposium 133
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Kennedy, A.S., Dezarn, W.A., McNeillie, P. (2008). Results in Liver Metastatic Colorectal Cancer. In: Bilbao, J.I., Reiser, M.F. (eds) Liver Radioembolization with 90Y Microspheres. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-35423-9_11
Download citation
DOI: https://doi.org/10.1007/978-3-540-35423-9_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-35421-5
Online ISBN: 978-3-540-35423-9
eBook Packages: MedicineMedicine (R0)